High crystallinity, low oxide content, and low sintering lead to optimally performing mesoporous Si photocatalysts for solar-driven hydrogen production.
RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.